Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
Go back to Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug| (NASDAQ: ABVX) | Delayed: 105.18 -1.81 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.99 | 52 Week High | $ | |||
| Open | $107.00 | 52 Week Low | $ | |||
| Day High | $107.19 | P/E | N/A | |||
| Day Low | $104.38 | EPS | $ | |||
| Volume | 189,928 | |||||
